Seres Therapeutics board member Hans-Juergen Woerle resigns, effective May 31, 2026

Seres Therapeutics, Inc.

Dr. Woerle resigned from the board and all committees, effective May 31, 2026.
Departure is not due to any disagreement with Seres' operations, policies, or practices.
No replacement or additional board changes were announced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Hans-Juergen Woerle

member of the board of directors

MCRB · Seres Therapeutics, Inc.

Effective: 2026-05-31
Filed: June 1, 2026, 4:30 PM ET

On May 30, 2026, Hans-Juergen Woerle, M.D., Ph.D. resigned from his position as a member of the board of directors of Seres Therapeutics, Inc. (the “Company”) and on the committees on which he serves, effective May 31, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Hans-Juergen Woerle resigned as member of the board of directors at Seres Therapeutics, Inc..

Action: resigned
Role: member of the board of directors

Exact text from the filing

On May 30, 2026, Hans-Juergen Woerle, M.D., Ph.D. resigned from his position as a member of the board of directors of Seres Therapeutics, Inc. (the “Company”) and on the committees on which he serves, effective May 31, 2026.

View on SEC.gov

Seres Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-251548

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.